Uncategorized

United Therapeutics pays $140M for thymic cell therapy startup

United Therapeutics has paid $140 million to buy Thymmune Therapeutics for preclinical regenerative cell therapies focused on the thymus.​Read More

Published

on

United Therapeutics has paid $140 million to buy Thymmune Therapeutics for preclinical regenerative cell therapies focused on the thymus.​Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version